The US Food and Drug Administration granted approval for Empliciti in combination with two other therapies to treat people with multiple myeloma who have received one to three prior medications. Multiple myeloma is a form of blood cancer that occurs in infection-fighting plasma cells found in the bone marrow.
Are you up for a challenge?
